These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17492509)

  • 1. Aging and the growth hormone/insulin like growth factor-I axis.
    Sherlock M; Toogood AA
    Pituitary; 2007; 10(2):189-203. PubMed ID: 17492509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does growth hormone prevent aging in the healthy elderly with low serum insulin-like growth factor-I ?
    Lee KO; Liao L; Mukherjee JJ
    Mech Ageing Dev; 2004 Apr; 125(4):291-5. PubMed ID: 15063105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic growth hormone-insulin-like growth factor-I axis across the human life span.
    Ghigo E; Arvat E; Gianotti L; Lanfranco F; Broglio F; Aimaretti G; Maccario M; Camanni F
    J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1493-502. PubMed ID: 11202226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The somatopause: an indication for growth hormone therapy?
    Toogood AA
    Treat Endocrinol; 2004; 3(4):201-9. PubMed ID: 16026102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GH and ageing: Pitfalls and new insights.
    Bartke A; Darcy J
    Best Pract Res Clin Endocrinol Metab; 2017 Feb; 31(1):113-125. PubMed ID: 28477727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatopause reflects age-related changes in the neural control of GH/IGF-I axis.
    Giordano R; Lanfranco F; Bo M; Pellegrino M; Picu A; Baldi M; Balbo M; Bonelli L; Grottoli S; Ghigo E; Arvat E
    J Endocrinol Invest; 2005; 28(3 Suppl):94-8. PubMed ID: 16042366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone-releasing hormone and growth hormone-releasing peptide as therapeutic agents to enhance growth hormone secretion in disease and aging.
    Thorner MO; Chapman IM; Gaylinn BD; Pezzoli SS; Hartman ML
    Recent Prog Horm Res; 1997; 52():215-44; discussion 244-6. PubMed ID: 9238854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ageing, growth hormone and physical performance.
    Lanfranco F; Gianotti L; Giordano R; Pellegrino M; Maccario M; Arvat E
    J Endocrinol Invest; 2003 Sep; 26(9):861-72. PubMed ID: 14964439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the somatopause an indication for growth hormone replacement?
    Savine R; Sönksen PH
    J Endocrinol Invest; 1999; 22(5 Suppl):142-9. PubMed ID: 10442584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone secretion in the elderly: ageing and the somatopause.
    Martin FC; Yeo AL; Sonksen PH
    Baillieres Clin Endocrinol Metab; 1997 Jul; 11(2):223-50. PubMed ID: 9403121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associated hormonal decline in aging: is there a role for GH therapy in aging men?
    Lombardi G; Di Somma C; Rota F; Colao A
    J Endocrinol Invest; 2005; 28(3 Suppl):99-108. PubMed ID: 16042367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-dependent changes in body composition in postmenopausal Japanese women: relationship to growth hormone secretion as well as serum levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
    Sugimoto T; Nakaoka D; Nasu M; Kanzawa M; Sugishita T; Chihara K
    Eur J Endocrinol; 1998 Jun; 138(6):633-9. PubMed ID: 9678529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statement by the Growth Hormone Research Society on the GH/IGF-I axis in extending health span.
    Thorner MO
    J Gerontol A Biol Sci Med Sci; 2009 Oct; 64(10):1039-44. PubMed ID: 19587105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into a role of GH secretagogues in reversing the age-related decline in the GH/IGF-I axis.
    Frutos MG; Cacicedo L; Fernández C; Vicent D; Velasco B; Zapatero H; Sánchez-Franco F
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1140-52. PubMed ID: 17684105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?
    Giannoulis MG; Martin FC; Nair KS; Umpleby AM; Sonksen P
    Endocr Rev; 2012 Jun; 33(3):314-77. PubMed ID: 22433122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The somatotropic axis and aging: mechanisms and persistent questions about practical implications.
    Bartke A
    Exp Gerontol; 2009; 44(6-7):372-4. PubMed ID: 19371777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1.
    Thum T; Hoeber S; Froese S; Klink I; Stichtenoth DO; Galuppo P; Jakob M; Tsikas D; Anker SD; Poole-Wilson PA; Borlak J; Ertl G; Bauersachs J
    Circ Res; 2007 Feb; 100(3):434-43. PubMed ID: 17234973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of growth hormone and insulin-like growth factor-1 on the aging cardiovascular system and its progenitor cells.
    Devin JK; Young PP
    Curr Opin Investig Drugs; 2008 Sep; 9(9):983-92. PubMed ID: 18729005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.